Skip to main content
. 2023 May 12;13(5):792. doi: 10.3390/brainsci13050792

Table 2.

Selected studies that reported IGF’s relationship with neurochemical factors.

Author and Year Sample Methods IGF Measure Relevant Findings
Robson et al., 2015 [22] 34 healthy adults MEG, MRS, visual gratings Power IGF: 52.5 ± 4.4 Hz, ~45–65 Hz. No correlation of IGF with V1 surface area and thickness. Positive correlation of IGF with V1 GABA (R = 0.34), but insignificant after including age as a covariate
Wyss et al., 2017 [24] 15 healthy adults EEG, MRS, auditory stimulation Power IGF: ~30–160 Hz. No correlation of IGF with GABA and glutamate
Chen et al., 2014 [29] 12 adults with schizophrenia; 12 healthy adults EEG, MRS, working memory assessment Amplitude IGF: ~30–50 Hz. Positive correlation of IGF with DLPFC GABA (r = 0.58)
Lally et al., 2014 [30] 14 healthy adults EEG, MRI, categorization task Power Negative correlation of IGF with glutamate concentration in the occipital cortex (r = −0.54)
Morgan et al., 2008 [38] Wistar rats In vitro LFP, arachidonylcyclopropylamide
(ACPA) and LY320135
Power In hippocampal entorhinal cortex slices, IGF pre-injection: 40.7 ± 2.4 Hz; IGF after CB1R agonist (ACPA) injection decreased to 35.6 ± 1.8 Hz, but returned to 41.2 ± 1.8 Hz after CB1R antagonist (LY320135) injection
Pálhalmi et al., 2004 [39] Wistar rats In vitro LFP, carbachol and (RS)-3,5-dihydroxyphenylglycine (DHPG) Power IGF post-carbachol: 31.5 ± 0.7 Hz; IGF post-DHPG: 41.2 ± 0.6 Hz. Positive correlation of IGF with DHPG dosage
Shaw et al., 2013 [51] 37 healthy adults:
19 remitted depression (RD), 18 never depressed (ND)
MEG, MRS, visual gratings Power IGF in RD: 57.64 Hz, IGF in ND: 55.83 Hz, non-significant difference. No correlation of IGF with occipital GABA
Edden et al., 2009 [57] 13 healthy adults MEG, MRS, visual gratings Amplitude IGF: 50.9 ± 1.3 Hz, 43.5–58.0 Hz. Positive correlation of IGF with V1 GABA concentration (r = 0.67)
Muthukumaraswamy et al., 2009 [58] 12 healthy adults MEG, MRS, fMRI, visual gratings Amplitude IGF: 40–66 Hz. Positive correlation of IGF with V1 GABA concentration (R = 0.68)
Gaetz et al., 2011 [59] 9 healthy adults MEG, MRI, MRS, visual stimuli and motor responses Amplitude IGF: ~70–80 Hz. Positive correlation of IGF with M1 GABA concentration: R2 = 0.46 (3.9 Hz increase per 0.1 GABA increase)
Cousijn et al., 2014 [60] 50 healthy adults MEG, MRS, visual gratings Power IGF: ~40–75 Hz. No correlation of IGF with occipital GABA and glutamate
Kujala et al., 2015 [61] 13 healthy adults MEG, PET, MRI, working memory assessment Amplitude IGF: ~40–100 Hz. Positive correlation of IGF with GABAA receptor density in V1 (rho = 0.74)
Campbell et al., 2014 [62] 16 healthy adults MEG, alcohol, visual gratings, finger movement task Amplitude IGF pre-alcohol: ~55 Hz; IGF post-alcohol: ~50 Hz. Drug and time interaction for visual IGF, where IGF decreased after alcohol administration
Shaw et al., 2015 [63] 20 healthy adults MEG, MRI, visual gratings, ketamine Amplitude For high contrast gratings, IGF pre-ketamine: ~51 Hz; IGF post-ketamine: ~49 Hz
Lozano-Soldevilla et al., 2014 [64] 32 healthy adults MEG, lorazepam, working memory assessment Power IGF pre-lorazepam: >75 Hz; IGF post-lorazepam: <75 Hz
Magazzini et al., 2018 [65] 15 healthy adults MEG, tiagabine, visual gratings Power IGF after placebo: ~53 Hz; IGF after tiagabine: ~50 Hz
Kocsis et al., 2014 [66] Rats In vivo LFP, D4 receptor agonist A-412997 (Tocris) injections Power IGF pre-injection: 51 ± 1 Hz; IGF post-injection: 46 ± 2 Hz
Kühn et al., 2017 [67] 42 Wistar rats In vivo LFP, levodopa or apomorphine injections, behavioral testing Power IGF decreased with apomorphine dosage from ~65 Hz to ~60 Hz in Parkinson’s disease animal model and controls; IGF increased with levodopa dosage from ~60 Hz to ~65 Hz, only in controls
Craig and McBrain 2015 [68] Nkx2–1-cre:RCE and Htr3a-GFP mice. In vitro LFP, kainate Power Kainate evoked gamma in hippocampal slices. IGF in CA3 region: 52 ± 1.2 Hz, ~40–65 Hz; IGF in CA1 region: 63 ± 0.87 Hz, ~40–80 Hz

Abbreviations: ACPA—arachidonylcyclopropylamide; DHPG—(RS)-3,5-dihydroxyphenylglycine; DLPFC—dorsolateral prefrontal cortex; EEG—electroencephalogram; fMRI—functional magnetic resonance imaging; IGF—individual gamma frequency; LFP—local field potential; MEG—magnetoencephalogram; MRI—magnetic resonance imaging; MRS—magnetic resonance spectroscopy; PET—positron emission tomography.